Published in Cancer on March 01, 1976
Blood lymphocyte subpopulations in breast cancer patients following radiotherapy. Clin Exp Immunol (1977) 1.05
Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol (2012) 0.98
Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors. J Natl Compr Canc Netw (2015) 0.92
Follow-up studies on the immune status of patients with Hodgkin's disease after splenectomy and treatment, in relapse and remission. Br J Cancer (1977) 0.91
T- and B-lymphocyte subpopulations following radiotherapy for invasive squamous cell carcinoma of the uterine cervix. Clin Exp Immunol (1978) 0.82
Lymphopenia and its association with survival in patients with locally advanced cervical cancer. Gynecol Oncol (2015) 0.81
Effects of tumor irradiation on host T-regulatory cells and systemic immunity in the context of adoptive T-cell therapy in mice. J Immunother (2013) 0.80
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomas. J Neurooncol (2015) 0.79
T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix. Clin Exp Immunol (1977) 0.78
Immunological state of patients with carcinoma of the bronchus before and after radiotherapy. Thorax (1980) 0.78
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys (2015) 0.76
Patterns of Radiation-Associated Lymphopenia in Children with Cancer. Cancer Invest (2016) 0.75
Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells. Transplantation (1970) 5.37
The impact of managed care on patients' trust in medical care and their physicians. JAMA (1996) 3.61
A unique natural human IgG antibody with anti-alpha-galactosyl specificity. J Exp Med (1984) 3.07
Thymus cells of radiation-chimeras: TL phenotype, sensitivity to guinea-pig serum, and origin from donor cells. Nature (1965) 2.54
Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet (1999) 2.42
Privatization of psychiatric services. Am J Psychiatry (1988) 2.38
Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues. J Exp Med (1985) 2.37
Antigens of the thymus. Prog Allergy (1972) 2.36
Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates. Proc Natl Acad Sci U S A (1987) 2.27
The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J Immunol (1974) 2.19
Initiation sites for translation of sindbis virus 42S and 26S messenger RNAs. Cell (1975) 1.94
Management of mental health and substance abuse services: state of the art and early results. Milbank Q (1995) 1.90
Antigenic changes in lymph-node cells after administration of antiserum to thymus cells. Science (1969) 1.80
Serologic demonstration of a thymus-dependent population of lymph-node cells. J Immunol (1970) 1.79
On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metastasis Rev (2001) 1.78
Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum (1978) 1.74
On the limits of expanding health care reform: chronic care in prepaid settings. Milbank Q (1986) 1.67
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum (1982) 1.62
Anti-theta antibodies for detecting thymus-dependent lymphocytes in the immune response of mice to SRBC. Nature (1970) 1.61
Time domain dielectric spectroscopy study of human cells. II. Normal and malignant white blood cells. Biochim Biophys Acta (1999) 1.54
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer (1994) 1.51
A broader vision for managed care, Part 1: Measuring the benefit to communities. Health Aff (Millwood) (1998) 1.51
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum (1982) 1.51
Defective virus particles from Sindbis virus. Virology (1972) 1.44
Some aspects of the humoral and neutrophil functions in post-comatose nawareness patients. Brain Inj (1993) 1.42
Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood (1983) 1.41
Accessory nipples: any relationship to urinary tract malformation? Pediatr Dermatol (1992) 1.41
Absence of natural killer cells in a child with pure red blood cell aplasia. Am J Hematol (1990) 1.39
The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J Exp Med (1987) 1.38
The CD38 lymphocyte differentiation marker: new insight into its ectoenzymatic activity and its role as a signal transducer. Immunity (1997) 1.35
Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr Nephrol (1998) 1.32
Activated T cells in the synovial fluid of arthritic patients: characterization and comparison with in vitro activated human and murine T cells in cooperation with monocytes in cytotoxicity. J Immunol (1979) 1.24
Thymic deficiency in Down's syndrome. Pediatrics (1979) 1.23
Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest (1992) 1.22
Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med (1995) 1.20
Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest (2000) 1.20
Spontaneous occurrence of autoantibodies cytotoxic to thymus cells in the sera of mice of the 129 strain. Nature (1965) 1.20
Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay. Biochemistry (1990) 1.19
Psychological distress among male patients and male spouses: what do oncologists need to know? Ann Oncol (2009) 1.19
Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation (1998) 1.18
Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest (1986) 1.15
Response of superior vena cava syndrome to radiation therapy. Cancer (1976) 1.14
Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J Immunol (1989) 1.13
Effect of neuraminidase on serological properties of murine lymphoid cells. Transplant Proc (1971) 1.13
Subpopulations of human thymus cells differing in their capacity to form stable E-rosettes and in their immunologic reactivity. J Immunol (1975) 1.11
Characterization of cytotoxic isoantisera produced in R3 mice. I. Demonstration of antibodies against the theta-C3H isoantigen. Transplantation (1969) 1.09
Differential expression of alpha-GAL epitopes (Galalpha1-3Galbeta1-4GlcNAc-R) on pig and mouse organs. Transplantation (2000) 1.09
Prostate cancer: comparison of retrograde urethrography and computed tomography in radiotherapy planning. Int J Radiat Oncol Biol Phys (1994) 1.08
Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids. Cancer Res (1982) 1.08
Radiation therapy in the treatment of superior vena caval obstruction. Cancer (1978) 1.06
Establishment and characterization of a new leukaemic T-cell line (Peer) with an unusual phenotype. Int J Cancer (1980) 1.06
The natural anti-alpha-galactosyl IgG on human normal senescent red blood cells. Br J Haematol (1986) 1.05
Immune competence of newborn lymphocytes. Pediatrics (1980) 1.05
Suppressors of cancer cell proliferation from fig (Ficus carica) resin: isolation and structure elucidation. J Nat Prod (2001) 1.05
Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. Cancer Res (1999) 1.04
Project Safety Net: a health screening outreach and assessment program. Gerontologist (1993) 1.03
Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. J Biol Chem (1987) 1.02
Lectin-induced apoptosis of tumour cells. Glycobiology (1993) 1.02
Serological analysis of thymus and spleen grafts. J Exp Med (1968) 1.02
Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection. Cancer Res (1995) 1.01
Age-associated changes in subpopulations of human lymphocytes. Clin Immunol Immunopathol (1977) 1.01
Disclosure of HIV status to medical providers: differences by gender, "race," and immune function. Public Health Rep (2000) 1.01
Loss of thymus-distinctive serological characteristics in mice under certain conditions. Science (1967) 1.01
Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. J Autoimmun (2009) 1.00
Natural species-restricted attachment of human and murine T lymphocytes to various cells. Proc Natl Acad Sci U S A (1978) 1.00
The rise of proprietary health care. Bus Health (1985) 1.00
Porcine cartilage transplants in the cynomolgus monkey. III. Transplantation of alpha-galactosidase-treated porcine cartilage. Transplantation (1998) 0.99
Human prothymocytes. Membrane properties, differentiation patterns, glucocorticoid sensitivity, and ultrastructural features. J Exp Med (1980) 0.99
Rare Jatropha multifida intoxication in two children. J Emerg Med (2000) 0.98
Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor. Br J Dermatol (2001) 0.98
Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines. Eur J Haematol (1999) 0.98
Activated T cells in the synovial fluid of arthritic patients. II. In vitro activation of the autologous blood lymphocytes. J Immunol (1981) 0.98
A national study of psychiatric hospital care. Am J Psychiatry (1991) 0.98
Polyarteritis nodosa and familial Mediterranean fever: a report of 2 cases and review of the literature. J Rheumatol (1989) 0.98
Hereditary CD4+ T lymphocytopenia. Arch Dis Child (1998) 0.97
Effect of colchicine on immunoregulatory abnormalities in familial Mediterranean fever. Clin Exp Immunol (1983) 0.97
The development of the complement system after 28 weeks' gestation. Acta Paediatr (1997) 0.96
Properdin deficiency: molecular basis and disease association. Mol Immunol (2000) 0.96
Profits under pressure. The economic performance of investor-owned and nonprofit health maintenance organizations. Med Care (1986) 0.96
Ownership and mental-health services. A reappraisal of the shift toward privately owned facilities. N Engl J Med (1984) 0.96
Defining the minimal size of catalytically active primate alpha 1,3 galactosyltransferase: structure-function studies on the recombinant truncated enzyme. Glycobiology (1994) 0.95
Inhibition by carbohydrates of the cytotoxicity of heterologous sera for mouse thymus cells. Isr J Med Sci (1967) 0.95
Production of TCII (vitamin B12 transport protein) by mouse mononuclear phagocytes. Blood (1978) 0.95
Competitive bidding and states' purchase of services: the case of mental health care in Massachusetts. J Policy Anal Manage (1986) 0.95
The promise and pitfalls of purchase-of-service contracts. Hosp Community Psychiatry (1986) 0.94
The privatization of health care and physicians' perceptions of access to hospital services. Milbank Q (1987) 0.93
Inherited complement C3 deficiency: a defect in C3 secretion. Eur J Immunol (1994) 0.93
Cancer in married couples: higher or lower distress? J Psychosom Res (1998) 0.93
Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine. J Med Virol (2000) 0.92
Human T lymphocyte receptors for sheep red blood cells and specific antigens: are they identical sites on the cell membrane? J Immunol (1977) 0.92
Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations. J Immunol (1995) 0.91
Separation and characteristics of tumor-infiltrating lymphocytes in man. Contemp Top Immunobiol (1980) 0.91
Lymphocyte subpopulations in chronic active hepatitis: increase in lymphocytes forming stable E-rosettes. Clin Immunol Immunopathol (1975) 0.91
Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions. Clin Diagn Lab Immunol (1995) 0.91
Chronic illness and plan satisfaction under managed care. Health Aff (Millwood) (2000) 0.91